Creo Medical wins National Award for Innovation
At an awards event in London last week, the BVCA (British
Private Equity & Venture Capital Association) recognised Creo
Medical for the innovation of its electrosurgical platform, with
wide reaching potential applications.
Following the announcement on the regional award a few weeks
ago, Creo Medical has won the National Best for Innovation award in
the BVCA Management Team Awards for 2015.
Further recognition of the technology designed in collaboration
with the world class Gastroenterology team at St Mark’s Hospital,
London, the CROMA platform along with the Speedboat RS2 device has
been described as “the first new electrosurgical system in a
generation”. Providing a unique combination of bipolar
radiofrequency energy for precise cutting and microwave energy for
controlled coagulation the technology is designed to deliver
quicker, safer and more effective results.
Over 150 UK companies were nominated for the 2015 BVCA
Management Team Awards in seven categories. Nominations were
subject to rigorous due diligence and in-depth interviews by a
judging panel of leading industry figures.
Congratulating Creo Medical on winning this award Dr Richard
Thompson from Finance Wales’ technology venture investments team
said: “Creo Medical is an emerging med-tech leader and its CROMA
electrosurgical platform is ground breaking and has significant
potential to improve the outcomes of a range of medical
procedures. Creo had already been recognised as a Welsh
regional winner, so winning the national Best for Innovation award
is even more impressive and clearly demonstrates how truly
innovative CROMA is. Finance Wales is a long-term backer of
Creo Medical and it has made excellent progress since we helped to
relocate its headquarters to Wales. The company has a bright
future and we congratulate Craig and his team on their
Chris Hancock, Inventor & co-founder of Creo Medical said:
“This award will help further engage the creative spirit of the
company & lead to the development of exciting innovation in
medical devices solving unmet clinical needs”
The BVCA is the industry body for private equity and venture
capital in the UK, embracing over 230 private equity and venture
capital houses reinforcing the crucial role the industry plays in
the global economy as a catalyst for change and growth.